Academic literature on the topic 'Seborrheic Dermatitis'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Seborrheic Dermatitis.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Seborrheic Dermatitis"
Одинцова, Инна, and Анатолий Дюдюн. "The composition of microorganisms in the skin lesions focus in patients with seborrheic dermatitis." Dermatovenerology. Cosmetology. Sexopathology, no. 3-4 (November 28, 2019): 38–41. http://dx.doi.org/10.37321/dermatology.2019.3-4-05.
Full textAdhikary, Sahadev Kumar, Md Eakub Ali, Md Jamal Uddin, Shireen Akter, Masood Mohammad Abdul Aziz, Farhana Ferdaus, and Ratan Lal Dutta Banik. "A Study on Efficacy of Oral Itraconazole in the Treatment of Seborrheic Dermatitis." Faridpur Medical College Journal 16, no. 1 (October 3, 2021): 21–24. http://dx.doi.org/10.3329/fmcj.v16i1.55732.
Full textAbdulla, Farah Rukhsana, and Robert T. Brodell. "Seborrheic dermatitis." Postgraduate Medicine 117, no. 3 (March 2005): 43–44. http://dx.doi.org/10.3810/pgm.2005.03.1602.
Full textCotterill, Paul C. "Seborrheic Dermatitis." International Society of Hair Restoration Surgery 7, no. 6 (November 1997): 13.2–13. http://dx.doi.org/10.33589/7.6.13b.
Full textGupta, AK, and R. Bluhm. "Seborrheic dermatitis." Journal of the European Academy of Dermatology and Venereology 18, no. 1 (January 2004): 13–26. http://dx.doi.org/10.1111/j.1468-3083.2004.00693.x.
Full textSa�ar, Tuncer. "Seborrheic Dermatitis." Journal of Clinical and Analytical Medicine 2, no. 2 (May 1, 2011): 57–60. http://dx.doi.org/10.4328/jcam.116.
Full textNaldi, Luigi, and Alfredo Rebora. "Seborrheic Dermatitis." New England Journal of Medicine 360, no. 4 (January 22, 2009): 387–96. http://dx.doi.org/10.1056/nejmcp0806464.
Full textSchmidt, Jennifer A. "Seborrheic Dermatitis." Journal of the Dermatology Nurses' Association 3, no. 5 (September 2011): 294–99. http://dx.doi.org/10.1097/jdn.0b013e31822f48eb.
Full textGupta, Aditya K., Robyn Bluhm, Elizabeth A. Cooper, Richard C. Summerbell, and Roma Batra. "Seborrheic dermatitis." Dermatologic Clinics 21, no. 3 (July 2003): 401–12. http://dx.doi.org/10.1016/s0733-8635(03)00028-7.
Full textSchmidt, Jennifer A. "Seborrheic Dermatitis." Nurse Practitioner 36, no. 8 (August 2011): 32–37. http://dx.doi.org/10.1097/01.npr.0000399717.56736.1e.
Full textDissertations / Theses on the topic "Seborrheic Dermatitis"
Casas, Fernando Constantino. "A seborrheic dermatitis in pygmy goats." Thesis, University of Cambridge, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.385334.
Full textMoraes, Andrea Pinheiro de. "AvaliaÃÃo terapÃutica do pimecrolimo creme 1% no tratamento da dermatite seborrÃica da face de pacientes com HIV- Positivos." Universidade Federal do CearÃ, 2006. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=216.
Full textSeborrheic dermatitis (SD) is a one of the most common dermatosis in HIV-positive patients affecting between 40 to 80% of AIDS patients and 20 to 40% of HIV-positive patients. To investigate efficacy and safety of pimecrolimus cream 1% in HIV-positive patients with facial SD a phase II study was done. First of all 4 HIV-infected patients (Group A) with mild/severe SD were treated twice-daily with pimecrolimus cream 1% for 7 days and after this 21 HIV-infected patients (Group B) with mild/severe SD were treated twice-daily with pimecrolimus cream 1% for 14 days. Thereafter, treatment was discontinued and patients followed up for 5 weeks. Skin involvement (erythema, scaling, burning, pruritus, infiltration/papulation, excoriation and lichenification) at baseline, Days 7, 14, 21, 35 and 49 was assessed using a 4-point clinical score and digital photographs. Marked improvement was seen in clinical parameters at Day 7, with >= 90% patients clear of symptoms at Day 14. Erythema and scaling relapsed at Day 35 in approximately 50% of patients, but all symptoms were milder than at baseline. All patients responded to therapy, despite their immunologic status. Pimecrolimus cream represents a new, attractive and effective therapeutic option for facial SD in HIV-patients.
Schechtman, Regina Casz. "Seborrhoeic dermatitis and Malassezia species : an investigation in HIV positive patients." Thesis, King's College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.307506.
Full textJiun-WenGuo and 郭俊文. "The effect of human sebum on skin barrier and its role in the pathogenesis of seborrheic dermatitis." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/07156302507137933006.
Full text國立成功大學
臨床藥學與藥物科技研究所
102
Seborrheic dermatitis (SD) is a common, recurrent, chronic inflammatory skin disorder. It generally arises in areas with high density of sebaceous glands. Human sebum is a complex mixture of lipids, which is secreted by mammalian sebaceous glands associated with hair follicles, and forms a fluid film over the skin surface. The functions of sebum have been known to soften the skin, to regulate the water content of the epidermis, to inhibit the growth of gram-positive bacteria and to prevent an invasion of external organisms. It was hypothesized that the Malassezia yeasts consumed the saturated fatty acids released from the triglycerides, and left behind the unsaturated fatty acids which cause inflammation and irritation. However, up to the present, there is only very limited information about the effect of sebum on skin barrier and its role in the pathogenesis of SD. Two studies were designed to clarify the sebum effect on skin barrier and its role in pathogenesis in SD. In the first study, using a hairless mouse model, we clearly demonstrated the human sebum imparts detrimental effects on the skin permeability barrier both functionally and morphologically. The underlying mechanisms for sebum-induced barrier disruption are related directly to the interaction of sebum with the intracellular lipid lamellae of the stratum corneum (SC), thereby leading to increase the fluidity of SC intracellular lipids as demonstrated by ATR-FTIR spectroscopic measurement. Direct observation of the SC lipids by ruthenium tetroxide staining under electron microscope further confirm that intercellular lipid lamellae disorganization was the earliest morphological event following sebum application. The disruption of the skin barrier elicit an epidermal inflammatory cascade with the release of IL-1α, TNF-α, and IL-6 from the keratinocytes and later inflammatory cells infiltration in the upper epidermis. Although acute increase of these cytokines is crucial for skin barrier repair, in chronic barrier disruption, these cytokines cascade could have a harmful effect leading to cutaneous chronic inflammation. Supported by the epidermal TSLP staining and serum IgE data, and also in agreement with previous reports, we may conclude that sebum-induced dermatitis resembles irritant contact dermatitis rather than allergic dermatitis. In the second study, we reported the first human study to demonstrate elevated levels of oleic acid in both the SD sebum and in the control sebum collected 72 hr versus 24 hr post hair washing. Moreover, chronic applications of SD sebum and modified control sebum with similar oleic acid content onto mouse skin resulted in a higher TEWL value than application of control sebum. These results indicated possible involvement of C18 unsaturated fatty acid, and possibly others, in the pathogenesis of SD. In summary, results from both studies in concert identified possible relationships between sebum, irritant contact dermatitis, and SD. These findings may have therapeutic implications for the treatment of SD.
Kent, Keri. "The effectiveness of an oral homoeopathic preparation of selenium sulphide 12X in the management of dandruff (seborrheic dermatitis of the scalp)." Thesis, 2005. http://hdl.handle.net/10321/60.
Full textThis double-blind, placebo controlled study evaluated the effectiveness of Selenium sulphide 12X in the management of dandruff, as measured by a Visual Analogue Scale.
Zondi, Silindelo Minenhle. "The efficacy of a topical application comprising Calendula officinalis Ø and Olea europaea in the management of seborrheic dermatitis of the scalp (dandruff)." Thesis, 2017. http://hdl.handle.net/10321/2899.
Full textBackground Seborrheic dermatitis (SD) also known as pityriasis capitis is a common skin condition that affects mainly the scalp, causing scaly patches, red skin and stubborn dandruff (Preedy 2012). It has been reported that dandruff occurs in at least 50% of the world’s adult population and approximately 15% to 20% of the world’s total population (Mia 2016). Recent studies suggest that a scalp specific yeast called Malasseiza globosa appears to be responsible for SD (Zhang, Ran, Xie and Zhang 2013). Seborrheic dermatitis does not affect overall health but it can be uncomfortable and may cause embarrassment and low self-esteem (Del Rosso 2011; Preedy 2012). Anecdotal evidence at Ukuba Nesibindi Homoeopathic Community Clinic (UNHCC) indicated that patients with SD responded positively to Calendula officinalis Ø in combination with Olea europaea (olive oil). Notwithstanding this, there is a dearth of clinical data available to validate the aforesaid patient’s positive response. Hence this study aims to provide clinical evidence to prove or disprove patient’s response to Calendula officinalis Ø in combination with Olea europaea (olive oil). Objective The aim of this double blind randomized controlled study was to determine the efficacy of a topical application comprising Calendula officinalis Ø with Olea europaea in the management of SD of the scalp (dandruff). Material and methods The sample was selected by means of non-probability convenience sampling and consisted of 64 consenting participants between the ages of 18 to 50 years who had read the information letter and met the inclusion criteria. Participants were evenly distributed between the treatment and control groups according to the randomization list (32 participants in each group). The treatment group received Calendula officinalis Ø with Olea europaea and the control group received Olea europaea only. Three participants withdrew from the study resulting in only 61 completing the study, 30 from the control group and 31 from the treatment group. The study was conducted at the Durban University of Technology Homoeopathic Day Clinic (DUTHDC) under the supervision of a qualified and registered homoeopathic clinician. The duration of the study was six weeks with three consultations in total. Consultations took place on day 1, day 22 and day 43. At each consultation the participants were assessed by three individuals – the participant themselves, the researcher, and an independent party (the homoeopathic clinician on duty that day). The assessment tools included the Visual Analogue Scale (VAS) for the researcher and clinician consisting of the following categories: irritation, flaking, greasiness, percentage of the scalp involved and overall impression; and the Patient Perception Questionnaire (PPQ) for the patient consisting of the following categories: irritation, flaking, greasiness, itching and overall impression. This was accompanied by a detailed case history and physical examination performed by the researcher. Results Both the control and treatment groups displayed overall improvement in terms of Patient Perception Questionnaire and Visual Analogue Scale which means that a combination of Olea europeae with Calendula officinalis Ø (treatment group) and Olea europeae only (control group) were effective in the management of SD. There was no statistically significant difference between the effect of a combination of Olea europaea with Calendula officinalis Ø and Olea europaea only. In terms of the VAS and PPQ categories, there was a statistical significance between the groups, with the exception of irritation. Significant differences found were as follows: Flaking (clinician and patient rated p = 0.019) on visit 3 for the control group. Greasiness (clinician and patient rated p = 0.027) on visit 3 for the control group. Greasiness (researcher and patient rated p = 0.012) on visit 2 for the treatment group. Percentage of the scalp involved (researcher and clinician rated p = 0.013) on visit 2 for the treatment group. Overall impression (researcher and patient rated p = 0.026) on visit 2 for the control group. Overall impression (researcher and clinician rated p = 0.026) on visit 3 for the treatment group. Conclusion Both the combination of Olea europaea with Calendula officinalis Ø and Olea europaea only improve SD. Therefore, a topical application comprising Calendula officinalis Ø and Olea europaea is effective in the management of SD of the scalp (dandruff) and therefore permits further investigation.
M
Alkhawaja, Mariam Jamal. "A study of Th17 axis cytokines in a mouse model of cutaneous autoimmunity and of the association of the Human T-cell Leukemia Virus Type I and mycosis fungoides." Thesis, 2014. http://hdl.handle.net/1993/23252.
Full textRibeiro, Ana Isabel Freitas. "Biofilmes, microbiomas e infeções da pele." Master's thesis, 2019. http://hdl.handle.net/10284/8698.
Full textThis monograph aims to understand the concepts of biofilm and microbiome and address some skin infections that may result from the imbalance of the microbiome. Different areas of the skin have different ecosystems, thus being inhabited by different microorganisms. The microbiome represents the community of microorganisms that naturally inhabit the human body, thus forming part of the human identity. It is a complex ecosystem that brings together bacteria, fungi and viruses that live in commensalism with the host in various organs, including the skin. The skin is known as the largest organ of the human body and takes on great responsibilities, namely its thermoregulatory and protective function. The skin is constantly exposed to external aggressors and this is also where many immune system responses are manifested. Biofilms and microbiomes are currently relevant topics of study. Biofilms can be healthy or pathogenic. The microbiomes contain cells in planktonic state, sessile state and biofilms. The microbiome imbalance can be manifested by the presence of pathogenic biofilms. The aim of this paper is to review the literature from 1978 to 2019, focusing on the most recent contents, allowing to understand the dynamics of biofilms and microbiomes and to verify the influence of their imbalance on skin infections.
Books on the topic "Seborrheic Dermatitis"
Nigel, Blatchford, Shuster Sam, and Royal Society of Medicine Services (Great Britain), eds. Seborrhoeic dermatitis and dandruff - a fungal disease. London: Royal Society of Medicine Services, 1988.
Find full textParker, James N., and Philip M. Parker. Seborrheic dermatitis: A medical dictionary, bibliography, and annotated research guide to Internet references. San Diego, CA: ICON Health Publications, 2004.
Find full textOmodo-Eluk, Albinus Joel. Studies on Malassezia Pachydermatis from the skin of dogs with allergic dermatitis and from dogs with seborrhoeic dermatitis. Dublin: University College Dublin, 1998.
Find full textPublications, ICON Health. Seborrheic Dermatitis - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.
Find full textTreadwell, Patricia, ed. AM:STARs: Adolescent Dermatology, Vol. 22, No. 1. American Academy of Pediatrics, 2005. http://dx.doi.org/10.1542/9781581106398.
Full textJohn, Arneson. Clobetasol Propionate: The Ultimate User Guide Used to Treat Skin Conditions Such As Psoriasis, Seborrheic Dermatitis, Eczema and Other Skin Conditions. Lulu Press, Inc., 2021.
Find full textEsdaile, Ben. Eczema. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0250.
Full textBook chapters on the topic "Seborrheic Dermatitis"
Theisler, Charles. "Seborrhea/Seborrheic Dermatitis/Dandruff." In Adjuvant Medical Care, 313–15. New York: CRC Press, 2022. http://dx.doi.org/10.1201/b22898-308.
Full textMcGinley, Thomas, Kristine Cornejo, and Phelps Lambert. "Seborrheic Dermatitis." In Common Dermatologic Conditions in Primary Care, 87–97. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-18065-2_10.
Full textCurkova, Andrea Kovacikova, and Maria Simaljakova. "Seborrheic Dermatitis." In European Handbook of Dermatological Treatments, 867–77. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45139-7_87.
Full textJackson-Richards, Diane. "Seborrheic Dermatitis." In Dermatology Atlas for Skin of Color, 109–13. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54446-0_21.
Full textTreadwell, Patricia. "Seborrheic Dermatitis." In Atlas of Adolescent Dermatology, 57–59. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-58634-8_13.
Full textde Avelar Breunig, Juliano, and Marco Otavio Rocha Couto. "Seborrheic Dermatitis." In Dermatology in Public Health Environments, 429–47. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-33919-1_20.
Full textRudnicka, Lidia, Justyna Sicinska, Adriana Rakowska, and Olga Warszawik-Hendzel. "Seborrheic Dermatitis." In Atlas of Trichoscopy, 371–78. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-4486-1_30.
Full textNorman, Robert A., and Edward M. Young. "Seborrheic Dermatitis." In Atlas of Geriatric Dermatology, 113–17. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4579-0_16.
Full textCastillo, David E., Ilana Gunczler, Katlein França, and Jonette Keri. "Seborrheic Dermatitis." In Advances in Integrative Dermatology, 71–88. Chichester, UK: John Wiley & Sons, Ltd, 2019. http://dx.doi.org/10.1002/9781119476009.ch6.
Full textPicardo, Mauro, and Norma Cameli. "Seborrheic Dermatitis." In Evidence-Based Dermatology, 169–74. Oxford, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118357606.ch25.
Full textConference papers on the topic "Seborrheic Dermatitis"
Dimitrova, Jenya. "Therapeutic efficacy of local choleclaciferol in facial seborrheic dermatitis." In The 5th Virtual International Conference on Advanced Research in Scientific Areas. Publishing Society, 2016. http://dx.doi.org/10.18638/arsa.2016.5.1.826.
Full textKammerer, Susanne. "Roflumilast foam led to high response rates in seborrheic dermatitis." In EADV Congress 2022, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/b3195d65.
Full textKim, Manjae, Sewoong Kim, Minjoo Hwang, Jihun Kim, Minkyu Je, Jae Eun Jang, Dong Hun Lee, and Jae Youn Hwang. "Multispectral imaging based on a Smartphone with an external C-MOS camera for detection of seborrheic dermatitis on the scalp." In SPIE BiOS, edited by Daniel L. Farkas, Dan V. Nicolau, and Robert C. Leif. SPIE, 2017. http://dx.doi.org/10.1117/12.2251707.
Full textSahidah, Khaula Latifah Ramadhani, and Triana Agustin. "Correlation between Duration of Sun Exposure and Scalp Seborrheic Dermatitis Severity Score in the Dermatovenereology Clinic, Dr. Cipto Mangunkusumo General Hospital." In The 23rd Regional Conference of Dermatology 2018. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008152401320135.
Full text